The hidden costs of living with systemic sclerosis-associated interstitial lung disease
- PMID: 35538640
- DOI: 10.1111/resp.14275
The hidden costs of living with systemic sclerosis-associated interstitial lung disease
Keywords: autoimmune disease; economic cost; lung fibrosis; pulmonary fibrosis; systemic sclerosis.
Comment on
-
Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population-based cohort study.Respirology. 2022 May;27(5):341-349. doi: 10.1111/resp.14234. Epub 2022 Feb 27. Respirology. 2022. PMID: 35224821 Free PMC article.
References
REFERENCES
-
- Martin AB, Hartman M, Lassman D, Catlin A. National health expenditure accounts team. National health care spending in 2019: Steady growth for the fourth consecutive year. Health Aff. 2020;40:14-24.
-
- Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685-99.
-
- Calderon LM, Chaudhury M, Pope JE. Healthcare utilization and economic burden in systemic sclerosis: a systematic review. Rheumatology. 2021. https://doi.org/10.1093/rheumatology/keab847
-
- Knarborg M, Lokke A, Hilberg O, Ibsen R, Sikjaer MG. Direct and indirect cost of systemic sclerosis and associated interstitial lung disease: a nationwide population-based cohort study. Respirology. 2022;25(5):341-9.
-
- Hoffmann-Vold AM, Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, et al. Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort. Am J Respir Crit Care Med. 2019;200(10):1258-66.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
